CA2112488A1 - Methode et compositions pour le traitement des vomissements, des nausees et d'autres troubles a l'ondansetron optiquement pur s(-) - Google Patents
Methode et compositions pour le traitement des vomissements, des nausees et d'autres troubles a l'ondansetron optiquement pur s(-)Info
- Publication number
- CA2112488A1 CA2112488A1 CA002112488A CA2112488A CA2112488A1 CA 2112488 A1 CA2112488 A1 CA 2112488A1 CA 002112488 A CA002112488 A CA 002112488A CA 2112488 A CA2112488 A CA 2112488A CA 2112488 A1 CA2112488 A1 CA 2112488A1
- Authority
- CA
- Canada
- Prior art keywords
- ondansetron
- administered
- composition according
- pharmaceutically acceptable
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72172391A | 1991-06-26 | 1991-06-26 | |
US721,723 | 1991-06-26 | ||
US75080191A | 1991-08-27 | 1991-08-27 | |
US750,801 | 1991-08-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2112488A1 true CA2112488A1 (fr) | 1993-01-07 |
Family
ID=27110471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002112488A Abandoned CA2112488A1 (fr) | 1991-06-26 | 1992-06-25 | Methode et compositions pour le traitement des vomissements, des nausees et d'autres troubles a l'ondansetron optiquement pur s(-) |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0591395A1 (fr) |
JP (1) | JPH06509073A (fr) |
AU (1) | AU2254692A (fr) |
CA (1) | CA2112488A1 (fr) |
WO (1) | WO1993000075A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0591434A4 (en) * | 1991-06-26 | 1994-09-14 | Sepracor Inc | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
CN1078465C (zh) * | 1996-10-10 | 2002-01-30 | 沈阳药科大学 | 一种含奥坦西酮的透皮吸收制剂 |
US6548082B1 (en) | 1999-03-01 | 2003-04-15 | Sepracor Inc. | Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron |
US20030114475A1 (en) * | 2001-10-31 | 2003-06-19 | Addiction Therapies, Inc. | Methods for the treatment of addiction |
JP5004236B2 (ja) * | 2005-02-09 | 2012-08-22 | キッセイ薬品工業株式会社 | 口腔内崩壊錠 |
US20110288115A1 (en) * | 2010-05-24 | 2011-11-24 | Avmedis Llc | Treatment of vagally-mediated spectrum disorders |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
GB8516083D0 (en) * | 1985-06-25 | 1985-07-31 | Glaxo Group Ltd | Heterocyclic compounds |
GB8518745D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
US4845115A (en) * | 1986-12-17 | 1989-07-04 | Glaxo Group Limited | Method of medical treatment |
-
1992
- 1992-06-25 JP JP5501665A patent/JPH06509073A/ja active Pending
- 1992-06-25 CA CA002112488A patent/CA2112488A1/fr not_active Abandoned
- 1992-06-25 EP EP92914351A patent/EP0591395A1/fr not_active Withdrawn
- 1992-06-25 AU AU22546/92A patent/AU2254692A/en not_active Abandoned
- 1992-06-25 WO PCT/US1992/005377 patent/WO1993000075A1/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPH06509073A (ja) | 1994-10-13 |
EP0591395A1 (fr) | 1994-04-13 |
AU2254692A (en) | 1993-01-25 |
EP0591395A4 (fr) | 1994-08-31 |
WO1993000075A1 (fr) | 1993-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5962494A (en) | Methods for treating behavioral and other disorders using optically pure R(+) ondansetron | |
US5786357A (en) | Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone | |
US5942503A (en) | Use of Epinastine for the treatment of pain | |
DE60022692T2 (de) | (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen | |
EP0663828B1 (fr) | L'utilisation de (-) Cetirizine pour le traitement de la rhinite allergique et de l'asthme | |
US20090143344A1 (en) | Methods for treating or preventing symptoms of hormonal variations | |
KR100422492B1 (ko) | 중추신경계 질환을 치료하는데 유용한 광학적으로 순수한 (+)노르시사프라이드 | |
DE3822792A1 (de) | Neue anwendung von 5-ht(pfeil abwaerts)3(pfeil abwaerts) antagonisten | |
EP1145715A2 (fr) | Procédés d'utilisation de cisapride pour le traitement du reflux gastro-sophagien et d'autres troubles | |
Farthing | 5-Hydroxytryptamine and 5-hydroxytryptamine-3 receptor antagonists | |
CA2139636A1 (fr) | Methodes d'utilisation de la (+) cisapride pour le traitement du reflux gastro-oesophagien et d'autres troubles | |
WO2006072413A1 (fr) | Utilisation d'antagonistes selectionnes du cgrp en association avec d'autres substances medicinales contre la migraine, pour traiter la migraine | |
JPH08501083A (ja) | アレルギー疾患治療のためのノルアステミゾールの使用 | |
CA2112488A1 (fr) | Methode et compositions pour le traitement des vomissements, des nausees et d'autres troubles a l'ondansetron optiquement pur s(-) | |
EP2130539A1 (fr) | Comprimé thérapeutique pour une névralgie post-herpétique et procédé de traitement de la névralgie post-herpétique | |
WO1993010787A1 (fr) | Procedes et compositions therapeutiques de troubles du sommeil, d'attaques epileptiques et d'autres troubles au moyen de zopiclone (+) optiquement pure | |
AU3675299A (en) | Methods and compositions for treating emesis, nausa and other disorders using optically pure R(+) ondansetron | |
AU3143402A (en) | Methods and compositions for treating emesis, nausea and other disorders using optically pure R() ondansetron | |
CA1110170A (fr) | Composes hypotenseurs | |
IE903278A1 (en) | Use of dopamine-autoreceptor agonists in the treatment of¹drug dependency | |
US4904673A (en) | Agent for treating bradycardia and bradyarrhythmia | |
WO1993010788A1 (fr) | Procedes et compositions de traitement de troubles du sommeil, d'attaques epileptiques et d'autres troubles au moyen de zopiclone (-) optiquement pure | |
WO2001052854A1 (fr) | Antagonistes du recepteur nk1 utilises pour le traitement du syndrome des jambes sans repos | |
JPH01168615A (ja) | 制吐作用薬剤 | |
MXPA98003206A (en) | Employment of epinastin for the treatment of dolo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 19970625 |